A novel phosphodiesterase 5 inhibitor, RF26, improves memory impairment and ameliorates tau aggregation and neuroinflammation in the P301S tauopathy mouse model of Alzheimer's disease
Authors:
- 14 November 2024
- journal article
- research article
- Published by Elsevier in Experimental Neurology
- Vol. 384, 115058
Abstract
No abstract availableKeywords
Funding Information
- Mansoura University (MU-VET-21-10)
- Science and Technology Development Fund (41873)
This publication has 66 references indexed in Scilit:
- Protective effect of ginsenoside Rh2 on scopolamine‐induced memory deficits through regulation of cholinergic transmission, oxidative stress and the ERK‐CREB‐BDNF signaling pathwayPhytotherapy Research, 2020
- Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicineActa Neuropathologica, 2014
- Sildenafil, a selective phosphodiesterase type 5 inhibitor, enhances memory reconsolidation of an inhibitory avoidance task in miceBehavioural Brain Research, 2011
- Cyclic GMP and Nitric Oxide Synthase in Aging and Alzheimer's DiseaseMolecular Neurobiology, 2010
- Phosphodiesterase inhibition by sildenafil citrate attenuates a maze learning impairment in rats induced by nitric oxide synthase inhibitionPsychopharmacology, 2005
- Simultaneous activation of mouse main and accessory olfactory bulbs by odors or pheromonesJournal of Comparative Neurology, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- A genomic sequence analysis of the mouse and human microtubule-associated protein tauMammalian Genome, 2001
- Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's diseaseNeuron, 1989
- Developments of a water-maze procedure for studying spatial learning in the ratJournal of Neuroscience Methods, 1984